India, Aug. 13 -- Outlook Therapeutics, Inc. (OTLK) shares fell $0.26, or 23.75 percent, to $0.84 on Thursday, after the biopharmaceutical company priced a public offering of 55.56 million shares of common stock and accompanying warrants for gross proceeds of approximately $55 million.
The stock opened at $0.77 and traded between $0.76 and $0.85 during the session on the Nasdaq. It has traded in a 52-week range of $0.16 to $3.39. Trading volume reached 36.76 million shares, compared with an average daily volume of 22.43 million shares.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
The shares and warrants were priced at $0.99 per share and accompanying warrant, with the warrants exercisable at $1.10 ...